When ANXA2 expression levels were stratified according to nodal involvement—an indicator of breast cancer disease progression—we found a trend of increased ANXA2 expression in those who had nodal positive disease, but this was not statistically significant (p = 0.8674, Mann Whitney U test). The gene discussed is ANXA2; the disease is breast carcinoma.